Medical Research
(H12)
990 on File
BLUE GEN THERAPEUTICS FOUNDATION
Financial strength (30%)
46/100
Reliability (20%)
40/100
Effectiveness (25%)
51/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$50K
Total Revenue
$120K
Total Expenses
$-155,500
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
100.0%
Fundraising Efficiency
N/A
Operating Reserve
-15.55x
Liability-to-Asset
1736.8%
Revenue Diversification
100.0%
Compared with Peers
FY 2024
Compared with 726 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
100.0% | 84.5% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
-15.6 mo | 13.4 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
1736.8% | 0.4% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
100.0% | 93.3% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
890.0% | 9.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
33.3% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-142.4% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $50K | $120K | $-155,500 | 100.0% | — |
| 2023 | $5K | $90K | $-85,000 | 100.0% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.